The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work 020 7632 7200
Fax 020 7353 8895
Brighton, London, Manchester, Munich, Oxford

Christopher Wilkins


Work Department

Patents - Biotechnology





Christopher is a European and Chartered UK Patent Attorney.  He joined Dehns in 2007 after completing an Honours degree in Molecular Biology and Biochemistry from Durham University and a PhD and research fellowship in Plant Molecular Biology at Cambridge University. He became an Associate of the firm in 2013.


Type of clients and client work

Clients include both large multinational companies and SMEs with various sizes of patent portfolios, and work includes evaluating inventions for patentability, drafting patent specifications and all aspects of patent prosecution, including worldwide prosecution of patent families. Christopher also provides advice on infringement and validity, opposition of granted patents and assistance with the development and management of patent portfolios.



His work covers a wide range of biotechnology, medical and cosmetic fields. For instance, he has handled applications relating to: antibodies; artificial immune systems; pharmaceuticals, including peptide and protein based drugs; new medical uses of known biomolecules; virology and vaccination; newly identified genes and proteins and isolation methods; analyte detection methods and systems; genetically modified plants, animals and microorganisms; diagnostic assays; cosmetics; array technology; biofuel production; nucleic acid sequencing, amplification and identification; and molecular biology techniques.


  • UK Chartered Patent Attorney, 2011
  • European Patent Attorney, 2011
  • Certificate in IP Law, University of London, 2009
  • Fellow of the Chartered Institute of Patent Attorneys
  • Member of the European Patent Institute


BSc Hons Molecular Biology and Biochemistry, University of Durham, 2000

PhD, Plant Molecular Biology, University of Cambridge, 2004

Christopher was awarded his PhD in 2004 for research into the perception of the plant hormone cytokinin, and continued his research in this field as the ‘William Colton Fellow’ at Queens’ College, Cambridge University. During his fellowship he devoted a considerable amount of time to teaching, which included a lecture series in Plant and Microbial sciences for 2nd year undergraduates, as well as supervising undergraduate tutorial groups.

London: TMT (technology, media and telecoms)

PATMA: Patent attorneys

Within: PATMA: Patent attorneys

According to one client, 'the quality of advice at Dehns is outstanding' and the team is 'very effective at patent prosecution and invalidation attack and defence'. Leading the team is Alexander Piésold, Hanna Dzieglewska (head of biotechnology), Philip Towler (head of the chemical group), and John Tothill (head of engineering). Other key figures include Mark Bell, who worked with the US lighting products company Cree on its European patent applications and Laura Ramsay, who assisted Isansys Lifecar with the granting of a patent for its wireless cardiac monitoring device 'Lifetouch Sensor'. Patent portfolio management is a key specialty of Chris Goddard, who recently worked with Camurus on its portfolio. Matthew Hall and Adam Taylor conducted due diligence for EQT on the IP portfolio of its target company AutoStore. Associate Daniel Rowe drafted and filed the patent application for a test kit which measures bacteria and is used to detect bowel conditions. Alex Robinson, Barbara Rigby, Christopher Wilkins and Phillip Price are also recommended.

[back to top]

Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to